Rafael Ayerbe-Algaba

763 total citations
17 papers, 540 citations indexed

About

Rafael Ayerbe-Algaba is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Rafael Ayerbe-Algaba has authored 17 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Medicine, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Rafael Ayerbe-Algaba's work include Antibiotic Resistance in Bacteria (13 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rafael Ayerbe-Algaba is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rafael Ayerbe-Algaba collaborates with scholars based in Spain. Rafael Ayerbe-Algaba's co-authors include Younes Smani, Andrea Miró-Canturri, Jerónimo Pachón, María Eugenia Pachón-Ibáñez, Jiménez-Mejías Me, Viviana Sánchez-Encinales, Ángel Rodríguez-Villodres, Núria Bayó‐Puxán, Ernest Giralt and Meritxell Teixidò and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Rafael Ayerbe-Algaba

17 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Ayerbe-Algaba Spain 10 248 210 85 82 78 17 540
Anna Klöckner Germany 11 256 1.0× 298 1.4× 117 1.4× 111 1.4× 61 0.8× 17 658
Avinash Singh India 16 246 1.0× 262 1.2× 61 0.7× 88 1.1× 69 0.9× 36 817
Roberta J. Melander United States 14 277 1.1× 330 1.6× 96 1.1× 95 1.2× 77 1.0× 31 625
Julieanne M. Bostock United Kingdom 16 180 0.7× 409 1.9× 133 1.6× 65 0.8× 78 1.0× 21 747
Qipeng Cheng China 16 257 1.0× 217 1.0× 52 0.6× 83 1.0× 35 0.4× 38 591
Dongdong Zhao China 15 423 1.7× 197 0.9× 66 0.8× 80 1.0× 150 1.9× 49 802
Daina Zeng United States 9 136 0.5× 220 1.0× 97 1.1× 59 0.7× 47 0.6× 12 447
Gabriel Torrens Spain 13 368 1.5× 250 1.2× 32 0.4× 121 1.5× 60 0.8× 31 571
Grace E. Richmond United Kingdom 5 395 1.6× 234 1.1× 58 0.7× 96 1.2× 59 0.8× 6 604
Inga V. Leus United States 14 457 1.8× 238 1.1× 58 0.7× 165 2.0× 58 0.7× 28 649

Countries citing papers authored by Rafael Ayerbe-Algaba

Since Specialization
Citations

This map shows the geographic impact of Rafael Ayerbe-Algaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Ayerbe-Algaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Ayerbe-Algaba more than expected).

Fields of papers citing papers by Rafael Ayerbe-Algaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Ayerbe-Algaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Ayerbe-Algaba. The network helps show where Rafael Ayerbe-Algaba may publish in the future.

Co-authorship network of co-authors of Rafael Ayerbe-Algaba

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Ayerbe-Algaba. A scholar is included among the top collaborators of Rafael Ayerbe-Algaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Ayerbe-Algaba. Rafael Ayerbe-Algaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Me, Jiménez-Mejías, Rafael Ayerbe-Algaba, Juan Domínguez-Herrera, et al.. (2022). Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(1). 14–21. 4 indexed citations
2.
Miró-Canturri, Andrea, et al.. (2021). Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections. Microbiology Spectrum. 9(2). e0040321–e0040321. 6 indexed citations
3.
Miró-Canturri, Andrea, et al.. (2021). Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Antibiotics. 10(3). 336–336. 10 indexed citations
4.
Miró-Canturri, Andrea, Rafael Ayerbe-Algaba, R. Toro, et al.. (2021). Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. Pharmaceuticals. 14(6). 507–507. 7 indexed citations
5.
Miró-Canturri, Andrea, Rafael Ayerbe-Algaba, Jiménez-Mejías Me, Jerónimo Pachón, & Younes Smani. (2021). Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models. Antibiotics. 10(2). 194–194. 6 indexed citations
6.
Ayerbe-Algaba, Rafael, Núria Bayó‐Puxán, Jesús Seco, et al.. (2021). AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections. Frontiers in Microbiology. 12. 634323–634323. 7 indexed citations
7.
Ayerbe-Algaba, Rafael, et al.. (2020). Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 74 indexed citations
8.
Me, Jiménez-Mejías, Rafael Ayerbe-Algaba, Juan Domínguez-Herrera, et al.. (2020). Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Enfermedades Infecciosas y Microbiología Clínica. 40(1). 14–21. 4 indexed citations
9.
Ayerbe-Algaba, Rafael, et al.. (2020). Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria. Antibiotics. 9(1). 36–36. 5 indexed citations
10.
Miró-Canturri, Andrea, et al.. (2020). Repositioning rafoxanide to treat Gram-negative bacilli infections. Journal of Antimicrobial Chemotherapy. 75(7). 1895–1905. 19 indexed citations
11.
Ayerbe-Algaba, Rafael, Andrea Miró-Canturri, María Eugenia Pachón-Ibáñez, et al.. (2019). The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli. International Journal of Antimicrobial Agents. 54(4). 507–512. 24 indexed citations
12.
Miró-Canturri, Andrea, Rafael Ayerbe-Algaba, & Younes Smani. (2019). Drug Repurposing for the Treatment of Bacterial and Fungal Infections. Frontiers in Microbiology. 10. 41–41. 154 indexed citations
13.
Vila‐Farrés, Xavier, Rafael Ayerbe-Algaba, Mónica Varese, et al.. (2018). Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy. Journal of Antimicrobial Chemotherapy. 73(12). 3405–3412. 31 indexed citations
14.
Ayerbe-Algaba, Rafael, Jiménez-Mejías Me, Viviana Sánchez-Encinales, et al.. (2018). Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology. 8. 348–348. 53 indexed citations
15.
Ayerbe-Algaba, Rafael, et al.. (2018). Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB. mSphere. 3(2). 38 indexed citations
16.
Vila‐Farrés, Xavier, Viviana Sánchez-Encinales, Mónica Varese, et al.. (2017). Combating virulence of Gram-negative bacilli by OmpA inhibition. Scientific Reports. 7(1). 14683–14683. 63 indexed citations
17.
Me, Jiménez-Mejías, Viviana Sánchez-Encinales, Rafael Ayerbe-Algaba, et al.. (2016). Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Antimicrobial Agents and Chemotherapy. 60(8). 4464–4470. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Klöckner Breakdown of academic impact, for papers by Avinash Singh Breakdown of academic impact, for papers by Roberta J. Melander Breakdown of academic impact, for papers by Julieanne M. Bostock Breakdown of academic impact, for papers by Qipeng Cheng Breakdown of academic impact, for papers by Dongdong Zhao Breakdown of academic impact, for papers by Daina Zeng Breakdown of academic impact, for papers by Gabriel Torrens Breakdown of academic impact, for papers by Grace E. Richmond Breakdown of academic impact, for papers by Inga V. Leus
Rankless by CCL
2026